Diabetes risk score in Oman: A tool to identify prevalent type 2 diabetes among Arabs of the Middle East

Diabetes Research and Clinical Practice

Volumn 77, Issue 3, 2007, Pages 438-444

  Al Lawati, J A ^a   Tuomilehto, J ^b,c  

^a Department of the Non communicable Diseases Surveillance   (Oman)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

Diabetes; Oman; Risk score; Screening

Indexed keywords

GLUCOSE;

ADULT; AGED; AGING; ARAB; ARTICLE; BODY MASS; CLINICAL PROTOCOL; COHORT ANALYSIS; DENMARK; DIABETES MELLITUS; DIABETES RISK SCORE; FAMILY HISTORY; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; OMAN; ORAL GLUCOSE TOLERANCE TEST; POPULATION RISK; PREDICTION; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SCREENING TEST; SEX DIFFERENCE; STATISTICAL MODEL; THAILAND; WAIST CIRCUMFERENCE;

ADULT; ARABS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MIDDLE EAST; OMAN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 34547671064     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.01.013     Document Type: Article

References (31)

1. World Health Organization, The World Health Report 2002: Reducing Risks, Promoting Healthy Life. WHO, Geneva, 2002.
2. Al-Lawati J.A., Al Riyami A.M., Mohammed A.J., and Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet. Med. 19 11 (2002) 954-957
3. Al-Mahroos F., and McKeigue P.M. High prevalence of diabetes in Bahrainis, associations with ethnicity and raised plasma cholesterol. Diabet. Care 21 6 (1998) 936-942
4. Al-Nuaim A.R. Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia. Diabet. Med. 14 7 (1997) 595-602
5. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 18 (2001) 1343-1350
6. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N. Engl. J. Med. 6 346 (2002) 393-403
7. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 9323 (2002) 2072-2077
8. Engelgau M.M., Colagiuri S., Ramachandran A., Borch-Johnsen K., and Narayan K.M. Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. Diabet. Technol. Ther. 6 6 (2004) 874-882
9. Baan C.A., Ruige J.B., Stolk R.P., Witteman J.C., Dekker J.M., Heine R.J., et al. Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabet. Care 22 2 (1999) 213-219
10. Franciosi M., De Berardis G., Rossi M.C., Sacco M., Belfiglio M., Pellegrini F., et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (impaired glucose tolerance and long-term outcomes observational) study. Diabet. Care 28 5 (2005) 1187-1194
11. Saaristo T., Peltonen M., Lindstrom J., Saarikoski L., Sundvall J., Eriksson J.G., et al. Cross-sectional evaluation of the Finnish diabetes risk score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab. Vasc. Dis. Res. 2 2 (2005) 67-72
12. Mohan V., Deepa R., Deepa M., Somannavar S., and Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J. Assoc. Phys. India 53 (2005) 759-763
13. Aekplakorn W., Bunnag P., Woodward M., Sritara P., Cheepudomwit S., Yamwong S., et al. A risk score for predicting incident diabetes in the Thai population. Diabet. Care 29 8 (2006) 1872-1877
14. Engelgau M.M., Narayan K.M., and Herman W.H. Screening for type 2 diabetes. Diabet. Care 23 10 (2000) 1563-1580
15. Rathmann W., Martin S., Haastert B., Icks A., Holle R., Lowel H., et al. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch. Intern. Med. 165 4 (2005) 436-441
16. Lindstrom J., and Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabet. Care 26 3 (2003) 725-731
17. Glumer C., Carstensen B., Sandbaek A., Lauritzen T., Jorgensen T., and Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabet. Care 27 3 (2004) 727-733
18. Asfour M.G., Lambourne A., Soliman A., Al-Behlani S., Al-Asfoor D., Bold A., et al. High prevalence of diabetes mellitus and impaired glucose tolerance in the Sultanate of Oman: results of the 1991 national survey. Diabet. Med. 12 12 (1995) 1122-1125
19. Al-Lawati J.A., Mohammed A.J., Al-Hinai H.Q., and Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabet. Care 26 6 (2003) 1781-1785
20. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15 7 (1998) 539-553
21. American Diabetes Association. American diabetes alert. Diabet. Forecast 46 54 (1993)
22. Herman W.H., Smith P.J., Thompson T.J., Engelgau M.M., and Aubert R.E. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabet. Care 18 3 (1995) 382-387
23. Ruige J.B., de Neeling J.N., Kostense P.J., Bouter L.M., and Heine R.J. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabet. Care 20 4 (1997) 491-496
24. Silventoinen K., Pankow J., Lindstrom J., Jousilahti P., Hu G., and Tuomilehto J. The validity of the Finnish diabetes risk score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur. J. Cardiovasc. Prev. Rehabil. 12 5 (2005) 451-458
25. Glumer C., Vistisen D., Borch-Johnsen K., and Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabet. Care 29 2 (2006) 410-414
26. Rich S.S. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 39 11 (1990) 1315-1319
27. Kekalainen P., Sarlund H., Pyorala K., and Laakso M. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabet. Care 22 1 (1999) 86-92
28. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabet. Care 21 Suppl. 2 (1998) B19-B26
29. Tuomilehto J., and Lindstrom J. The major diabetes prevention trials. Curr. Diab. Rep. 3 2 (2003) 115-122
30. Abdul-Rahim H.F., Holmboe-Ottesen G., Stene L.C., Husseini A., Giacaman R., Jervell J., et al. Obesity in a rural and an urban Palestinian West Bank population. Int. J. Obes. Relat. Metab. Disord. 27 1 (2003) 140-146
31. Al-Lawati J.A., and Jousilahti P.J. Prevalence and 10-year secular trend of obesity in Oman. Saudi Med. J. 25 3 (2004) 346-351